Yashoda Hospitals in Hyderabad saves 20-year-old's life with innovative Pulmonary Thrombectomy device, preventing long-term ...

The ability to characterize the pulmonary circulation more fully paved the way for many advances. In the 1950s, Dr David ...

The Global Pulmonary Arterial Hypertension (PAH) Treatment Market is set for steady growth, with an estimated market size of ...

New data suggests clinicians may be slower to recognize sepsis in people with pulmonary arterial hypertension.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Advancements and Projections in the Global Pulmonary Arterial Hypertension Market: Insights, Trends, Opportunities, and ...

An independent data monitoring committee has recommended terminating the ZENITH study early based on the results.

Winrevair lowered death or transplant risk in adults with PAH functional class 3-4 at high risk of dying; all in study may ...

News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

Positive study results for Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent ...